A detailed history of Black Rock Inc. transactions in Nkarta, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 4,059,362 shares of NKTX stock, worth $23.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,059,362
Previous 2,825,506 43.67%
Holding current value
$23.2 Million
Previous $30.5 Million 21.45%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$5.27 - $10.82 $6.5 Million - $13.4 Million
1,233,856 Added 43.67%
4,059,362 $24 Million
Q1 2024

May 10, 2024

BUY
$5.59 - $15.71 $1.27 Million - $3.56 Million
226,305 Added 8.71%
2,825,506 $30.5 Million
Q4 2023

Feb 13, 2024

SELL
$1.31 - $6.6 $380,760 - $1.92 Million
-290,657 Reduced 10.06%
2,599,201 $17.2 Million
Q3 2023

Nov 13, 2023

SELL
$1.39 - $2.29 $202,933 - $334,328
-145,995 Reduced 4.81%
2,889,858 $4.02 Million
Q2 2023

Aug 11, 2023

SELL
$2.19 - $5.17 $407,653 - $962,359
-186,143 Reduced 5.78%
3,035,853 $6.65 Million
Q1 2023

May 12, 2023

BUY
$3.37 - $6.3 $86,366 - $161,456
25,628 Added 0.8%
3,221,996 $11.4 Million
Q4 2022

Feb 13, 2023

BUY
$5.14 - $14.35 $4.73 Million - $13.2 Million
920,516 Added 40.45%
3,196,368 $19.1 Million
Q3 2022

Nov 14, 2022

BUY
$12.27 - $18.39 $210,921 - $316,124
17,190 Added 0.76%
2,275,852 $30 Million
Q2 2022

Aug 12, 2022

BUY
$7.77 - $19.44 $7.81 Million - $19.5 Million
1,004,956 Added 80.16%
2,258,662 $27.8 Million
Q1 2022

May 12, 2022

SELL
$8.66 - $14.99 $386,452 - $668,928
-44,625 Reduced 3.44%
1,253,706 $14.3 Million
Q4 2021

Feb 10, 2022

SELL
$12.79 - $26.88 $804,337 - $1.69 Million
-62,888 Reduced 4.62%
1,298,331 $19.9 Million
Q3 2021

Nov 09, 2021

BUY
$26.67 - $38.76 $223,841 - $325,312
8,393 Added 0.62%
1,361,219 $37.9 Million
Q2 2021

Aug 11, 2021

BUY
$23.94 - $36.68 $32.4 Million - $49.6 Million
1,352,826 New
1,352,826 $42.9 Million

Others Institutions Holding NKTX

About Nkarta, Inc.


  • Ticker NKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,656,800
  • Market Cap $278M
  • Description
  • Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...
More about NKTX
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.